Product Information
NYSTATIN-TRIAMCINOLONE OINTM is a generic product labeled by Encube Ethicals, Inc., priced at $0.3178 per GM under NDC 21922003104. Its NADAC has been published 356 times since Oct 30, 2019.
FDA first approved this application on Jan 31, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922003104
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207741FDA Approved
1/31/2017
TE Code
AT
On Market Since
9/28/2019
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTM has been published 356 times since Oct 30, 2019, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3178 per GM |
|---|---|
| All-time high | $0.6644 (Nov 11, 2020) |
| All-time low | $0.2317 (May 22, 2024) |
| 52-week high | $0.3817 |
| 52-week low | $0.2997 |
| Median price | $0.3731 |
| Average price | $0.4108 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 356 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTM, manufactured by Encube Ethicals, Inc., is $0.3178 per GM (NDC 21922003104), effective Aug 19, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has declined 35.9%. It has been tracked across 356 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTM?
Since Oct 30, 2019, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has ranged from a low of $0.2317 (May 22, 2024) to a high of $0.6644 (Nov 11, 2020), with a median of $0.3731 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTM?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE OINTM, is $0.1910 per GM — about 40% below NYSTATIN-TRIAMCINOLONE OINTM.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTM?
NYSTATIN-TRIAMCINOLONE OINTM (NDC 21922003104) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.